The advisory firm projects this increase will occur despite market constraints that include intensified competition, generic erosion and an increasingly stringent regulatory and reimbursement environment. The antibiotics market is driven primarily by the increasing prevalence of multidrug-resistant infections as well as an aging population who are at increased risk of developing serious infections that require hospital treatment.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The drugs of highest interest to drug developers include those targeting nosocomial pneumonia, bloodstream infections, skin and skin structure/surgical site infections and urinary tract infections.
Related Articles on Hospital Infections:
Covidien Discontinuing Non-Sterile Alcohol Prep Pads
Hospitals to Fight C. Difficile Through National Initiative for Antimicrobial Stewardship
Tennessee Hospitals Decreased Rate of Central Line Infections to 22% Below National Baseline
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
